Together, these studies suggest that the activity of a cardiomyocyte-specific RE driving PRRX1 expression could perceivably be perturbed by a common variant associated with increased AF risk, leading to reduced expression of PRRX1 in cardiomyocytes of risk allele carriers and deregulation of atrial gene expression and function. Here, PRRX1 is linked to atrial fibrillation.